FBN’s Charles Payne on the shifting trends in how Americans eat.
Dr. Joseph Gulfo on FDA regulation and delays on sunscreen products and obesity drugs.
Consumer Reports Deputy Content Editor Lisa Gill on the potential health risks of pain medication.
UNC Assistant Professor of Medicine Dr. Kevin Campbell and Emergency Room Nurse Practitioner Erin Tolbert on the chemical Triclosan used in Colgate toothpaste.
VMR Products CEO and co-founder Jan Verleur on the company and the government’s regulations for e-cigarettes.
Johns Hopkins professor emeritus Dr. Ben Carson discusses the risk of Ebola and making a presidential run in 2016.
FBN’s Adam Shapiro on the highlights from the day in the markets.
Mount Sinai Health System CEO Ken Davis weighs in on the Ebola virus.
NYU Langone Medical Center’s Dr. Natalie Azar on the Ebola outbreak in Africa.
Sarepta Therapeutics CEO Chris Garabedian on its experimental drug to treat Ebola.
Dr. Devi Nampiaparampil on the Ebola virus and the effectiveness of the ZMapp treatment.
Scripps University Professor Erica Saphire on the Ebola virus and how the experimental ZMapp treatment works.
Low-T Clinic owner Mike Sisk and Urologist Dr. David Samadi on the potential benefits and risks of testosterone treatments.
Consumer Reports Deputy Content Editor Lisa Gill and FNC Medical A-Team ‘s Dr. Manny Alvarez on the shelf life of medication.
FBN’s Gerri Willis on what expiration dates on medical bottles really mean.
AHA E-Cigarette Paper author Dr. Aruni Bhatnagar on the potential dangers of e-cigarettes.
Smoke Free Alternative Trade Association President Phil Daman weighs in on e-cig regulations and backlash against the industry.
Belpointe Asset Management Chief Strategist David Nelson, FBN’s Charles Payne, retail analyst Hitha Prabhakar, Penn Financial Group founder Matt McCall and FBN’s Tracy Byrnes debate the outlook for Edwards Lifesciences.
Center for Food Safety Policy Director Elizabeth Kucinich on mounting concerns about food safety.
FOX News Medical A-Team’s Dr. Manny Alvarez on why the FDA process for approving sunscreen is slow.